Ovid Therapeutics Inc.

Historical 13F Holders

Symbol
OVID
CUSIP
690469101
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 85 46.4 M $14.5 M
2024 Q4 85 47.6 M $44.4 M
2024 Q3 79 47.8 M $56.4 M
2024 Q2 80 47.6 M $36.6 M
2024 Q1 88 52.0 M $159 M
2023 Q4 82 53.5 M $172 M
2023 Q3 65 42.3 M $163 M
2023 Q2 72 41.0 M $135 M
2023 Q1 64 38.7 M $99.8 M
2022 Q4 63 38.8 M $72.1 M
2022 Q3 61 35.6 M $65.5 M
2022 Q2 58 34.6 M $74.5 M
2022 Q1 65 35.1 M $110 M
2021 Q4 72 34.3 M $110 M
2021 Q3 77 33.6 M $113 M
2021 Q2 87 33.4 M $131 M
2021 Q1 96 36.3 M $146 M
2020 Q4 94 27.8 M $64.9 M
2020 Q3 100 25.1 M $144 M
2020 Q2 88 22.6 M $166 M
2020 Q1 62 16.7 M $49.7 M
2019 Q4 66 18.9 M $78.5 M
2019 Q3 40 8.21 M $26.6 M
2019 Q2 37 10.1 M $18.7 M
2019 Q1 51 12.3 M $21.7 M
2018 Q4 49 6.93 M $16.8 M
2018 Q3 53 7.68 M $43.5 M
2018 Q2 49 7.95 M $62.0 M
2018 Q1 49 7.34 M $51.9 M
2017 Q4 49 7.82 M $77.2 M
2017 Q3 42 7.22 M $61.5 M
2017 Q2 46 7.99 M $81.8 M